Endogastric Solutions, the maker of the Esophyx device announced on Monday(Aug 30th, 2010) that they had secured an additional $30 million dollars in funding. You can read more information about the Esophyx procedure from my previous post on it.
Thierry Thaure, President and Chief Executive Officer of EndoGastric Solutions commented: “Our technology offers significant clinical, economic and strategic benefits to our hospital and surgeon customers. Over the past two years, the EsophyX and StomaphyX product platforms have been embraced with a high level of enthusiasm by the surgeon community…
Esophyx is a fundoplication device & procedure that does not require incisions and instead is performed completely through the esophagus. Esophyx has come under fire recently for misleading statements & performance. It is marketed as a reversible procedure, but many have been told that their procedure cannot be undone. Additionally some have found no benefit or have had their symptoms worsen after the procedure. There is currently at least one lawsuit claiming Endogastric Solutions has made misleading statements regarding the Esophyx procedure.
Endogastric Solutions Press Release